Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
äŒæ¥ã³ãŒãSRDX
äŒç€ŸåSurmodics Inc
äžå Žæ¥Mar 04, 1998
æé«çµå¶è²¬ä»»è
ãCEOãHance (Robert B)
åŸæ¥å¡æ°389
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Mar 04
æ¬ç€Ÿæåšå°9924 West 74th Street
éœåžEDEN PRAIRIE
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·55344
é»è©±çªå·19525007000
ãŠã§ããµã€ãhttps://www.surmodics.com/
äŒæ¥ã³ãŒãSRDX
äžå Žæ¥Mar 04, 1998
æé«çµå¶è²¬ä»»è
ãCEOãHance (Robert B)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã